Related Experiment Video
Updated: Aug 17, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Prevention of resistance: a goal for dose selection for antimicrobial agents
1Division of Clinical Pharmacology, Clinical Research Institute, Albany Medical College and New York State Department of Health, Albany, NY 12208, USA. gldrusano@aol.com
Abstract:
Drug-resistant microorganisms have become a major problem around the world. In nosocomial and community settings, many important pathogens have demonstrated high-grade resistance to many of our most important agents. In addition, the adverse impact of resistance has not been limited to the bacterial realm. In chemotherapy to treat human immunodeficiency virus (HIV) and other viral diseases, resistance has become a major problem. We are starting to see the beginnings of a resistance problem, even among fungi. Strangely, little attention has been focused on the impact of dosing on the probability with which emergence of resistance occurs. After delineation of the pharmacodynamically linked variable, it is possible to generate dosing regimens that can lower the probability of resistance. In addition, circumstances exist in which combination therapy may be required (e.g., therapy of HIV and tuberculosis). Here, too, it is possible to optimize therapy to prevent resistance by understanding how the drugs in the regimen interact. We can do better with our choices of dose, schedule, and combinations of agents. We will need to lower the probability of resistance and maintain the utility of the drugs currently in our therapeutic armamentarium.
Insights
Optimizing drug dosing and combinations can significantly reduce the emergence of drug resistance in bacteria, viruses, and fungi. Understanding pharmacodynamics is key to developing effective treatment strategies and preserving antimicrobial utility.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Drug-resistant microorganisms pose a significant global health threat across various settings.
- Resistance is a growing problem not only in bacteria but also in viral and fungal pathogens.
- The impact of dosing strategies on the emergence of drug resistance remains under-explored.
Purpose of the Study:
- To investigate the influence of dosing on the probability of drug resistance emergence.
- To explore methods for optimizing drug regimens to minimize resistance.
- To enhance the long-term efficacy of antimicrobial and antiviral therapies.
Main Methods:
- Delineation of pharmacodynamically linked variables.
- Generation of optimized dosing regimens.
- Analysis of drug interactions in combination therapy.
Main Results:
- Pharmacodynamic understanding enables the creation of dosing strategies that lower resistance probability.
- Optimized combination therapies can be designed to prevent resistance, as seen in HIV and tuberculosis treatment.
- Improved choices in drug dose, schedule, and combinations are feasible.
Conclusions:
- Strategic adjustments in drug dosing, scheduling, and combinations can effectively mitigate resistance.
- A deeper understanding of pharmacodynamics is crucial for preserving the utility of existing therapeutics.
- Proactive measures are needed to combat the rising challenge of antimicrobial and antiviral resistance.
Related Concept Videos
Antibiotic Selection
Dosage Regimens: Designs and Approaches
Dosage Interval and Administration Route: Determination Methods
Antimicrobial Effectiveness
Microbiota Modulation by Antibiotics
Clinical Significance of Antibiotic Resistance

